Psychiatr. pro Praxi, 2003; 6: 273-275

Účinnost a snášenlivost léčby úzkostných poruch paroxetinem a alprazolamem

prof. MUDr. Alexandra Žourková CSc, MUDr. Lucie Pilařová, MUDr. Olga Kulísková Ph.D
Psychiatrická klinika LF MU a FN Brno

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žourková A, Pilařová L, Kulísková O. Účinnost a snášenlivost léčby úzkostných poruch paroxetinem a alprazolamem. Psychiatr. praxi. 2003;4(6):273-275.

Práce předkládá výsledky dvojitěslepé studie u 30 pacientů s úzkostnou poruchou srovnávající efekt farmakoterapie paroxetinem, alprazolamem nebo kombinací obou preparátů. Z výsledků vyplývá, že podávání paroxetinu samotného mělo jak nejvyšší účinnost, tak i snášenlivost.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gale Ch, Oakley-Browne M. Anxiety disorder. Brithish Medical Jornal 2000; 321: 1204-1207. Go to original source... Go to PubMed...
    2. Gould RA, Otto MV, Pollack MH, Yap L. Cognitive bahavioural and pharmacological treatment of generalised anxiety disroder: a preliminary meta-analysis, Behav. Ther. 1997; 28: 285-305. Go to original source...
    3. Guy W. (ed). ECDU Assessment Manual for Psychopharmacology, Rockville, U. S. DHEW, 1976. Go to original source...
    4. Hamilton M. Diagnosis and Rating of Anxiety. In: Lader MH. Studies of Anxiety, Brit. J. Psychiat., Spec. Pub., 1969; 3: 76-79.
    5. Herman E, Hovorka J, Praško J, Syrovátka J. Zlepšení kvality života při léčbě úzkostných poruch. In: Raboch J, Doubek P, Zrzavecká I. Psychiatrie v medicíně a medicína v psychiatrii, Galén, Praha, 2002: 51.
    6. Lingjaerde O, Ahlfors VG, Dencker SJ, Elgen K. The UKU side effects rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatr. Scand. Suppl., 1987: 1-100. Go to original source... Go to PubMed...
    7. Nutt DJ, Bell CJ, Potokar JP. Drug-treatment of chronic anxiety, Bailliere´s Clin. Psychiatry, 1995; 1: 565-594.
    8. Pidrman V, Bouček J. Generalizovaná úzkostná porucha - její farmakoterapie, Psychiatrie pro praxi, 2001; 2: 185-186.
    9. Praško J. Generalizovaná úzkostná porucha. In: Raboch J. (ed). Psychiatrie. Doporučené postupy psychiatrické péče, Galén, Praha, 1999: 77-97.
    10. Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza I. Paroxetine efficaccy in the treatment of generalized anxiety disorder. Acta Psychiatr. Scand. 1997; 95: 440-450. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.